Clinical Trial Update: Conversion of Prograf to Advagraf in Pediatric Renal Transplant Recipients [Phase 2, Phase 3]

View source ↗

Summary

This completed Phase 2/3 clinical trial from Seoul National University Hospital evaluates converting pediatric kidney transplant recipients from tacrolimus imme…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• Advagraf (tacrolimus)
• Prograf (Tacrolimus)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Kidney Transplantation, Pediatric Patients | Phase 2, Phase 3 | Status: COMPLETED